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Rare Presentation of a Massive Intermittent Upper Gastrointestinal Bleed
Bonnie Patek, DO, Matthew J. Sullivan, DO, and Shashin Shah, MD - Department of Medicine, Division of Gastroenterology
Lehigh Valley Health Network, Allentown, Pennsylvania

Background

Case Presentation

• Hemosuccus pancreaticus (HP) is a rare
cause of upper gastrointestinal bleeding
(UGIB) defined as bleeding from the ampulla
of Vater through the main pancreatic duct.
First described in 1970 by Dr. Sandblom
and characterized by GIB causing anemia1
that can easily be overlooked, originating
from a splenic artery aneurysm. Aneurysms
and pseudoaneurysms (PA) are not the only
causes of HP (Table 1).

•	A 35 year old male with complaints of progressive fatigue and generalized weakness over two weeks presents to an outside facility with
a past medical history of occult gastrointestinal bleed, previous alcohol abuse and acute pancreatitis. He denied melena, hematochezia,
hematemesis, nausea/vomiting, or chronic ibuprofen usage. Laboratory studies revealed a hemoglobin of 2.8 g/dL.
•	Initial esophagogastroduodenoscopy (EGD) revealed an actively bleeding mass at the major papilla, a non-bleeding ulceration at the GE
junction and absence of gastric and esophageal varices. Colonoscopy revealed no pathology.
o
•	The patient developed epigastric tenderness and spiking fevers as high as 102 F and elevated lipase level at 803 U/L upon presentation to our
institution.
•	Repeat EGD revealed a clean based ulcer in the distal esophagus and mild thickening of the duodenal sweep mucosa; no bleeding or mass at
the ampulla. Duodenal biopsies revealed signs of chronic inflammation.
•	A CT scan of the abdomen/pelvis revealed pancreatitis consistent with splenic artery pseudoaneurysm (image1), splenomegaly and a pancreatic head
lesion (image 2).
•	Interventional radiology performed an abdominal angiography identifying an 8mm splenic artery pseudoaneurysm from the proximal-mid
splenic artery with no active bleeding. Coil embolization (image 3) and repeat imaging confirmed no residual pseudoaneurysm (image 4) and a new
splenic infarct (image 5).
•	Follow-up MRI showed an ill-defined area of decreased attenuation in the head of the pancreas, fatty infiltrates within the liver and splenic infarct.
Patient was afebrile with no abdominal pain, a stable hemoglobin and vaccinated for encapsulated bacteria at time of discharge.

Table 1. Hemosuccus Pancreaticus Etiology 2-7
Acute Pancreatitis
Chronic Pancreatitis
Vascular malformations
Pancreatic tumors (cystadenocarcinoma , pancreatic carcinoma, serous cystic
neoplasm and neuroendocrine tumors, osteoclastoma)
Blunt abdominal trauma
Iatrogenic (laparoscopic surgery with vessel manipulation and EUS-FNA)
Pancreatic divisum (chronic pancreatitis)
Pancreatolithiasis
Rupture of true aneurysm (Atherosclerosis, vasculitis, fibromuscular dysplasia,
syphilitic affection, hereditary dystrophy of elastic tissue, alpha-1 antitrypsin
deficiency)

• Bleeding is intermittent and repetitive
and can be massive, but rare to cause
2
hemodynamic instability. Diagnosis is
difficult since endoscopy rarely reveals
active hemorrhaging and CT imaging or
angiography is needed to locate the source.
5
Interventional radiology for embolization
or surgical consult with use of intra6
operative pancreatoscopy are needed
based on the hemodynamic stability of the
patient and ability to identify the source of
hemorrhaging.
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Image. 1 - CT abdomen/pelvis with contrast
revealing pseudoaneurysm (arrow) located
in the proximal-mid splenic artery and
splenomegaly (not fully appreciated in this cut).

Image 2 - CT of abdomen/pelvis that
visualizes the nonspecific pancreatic
mass (arrow) located in the head of
the pancreas.

Image 3 - Angiography of
the splenic artery and the
pseudoaneurysm (arrow)prior
to coil embolization.

Image 4 - Angiography status post
coil embolization indicating no filling
of the splenic artery pseudoaneurysm
after coil placement.

Image 5 - CT of abdomen/pelvis status
post coil embolization with several areas of
infarction within the spleen (arrow). Coils
within the splenic artery are visualized.

Discussion
• HP is a rare disease with a male predominance (7:1). Pathophysiology is either from direct or indirect rupture of a vessel into the main pancreatic
duct. Weakening of the vessel wall forms the PA.
• PAs form in the setting of chronic or acute pancreatitis8 most commonly in the splenic artery (60%), gastroduodenal (20%), pancreaticoduodenal
(10%), hepatic (5%) and left gastric (2%)10 arteries.
7
		 - Complications include rupture into the gastrointestinal tract, a pseudocyst, peritoneal cavity, retroperitoneal space or adjacent organs.
7
		 - Frequency of rupture in the setting of pancreatitis is 5-10% and 20% with a pseudocyst.
10
10
		 - Mortality is 90-100% with a risk reduction to 12-57% if treated.
• Bleeding is intermittent due to clotting within the main pancreatic duct.9 Bleeding from the major ampulla is seldom seen with EGD. Residual blood
7
clots located near the ampulla with lack of other bleeding sources can be indicative of the disease.
5
• If a nondiagnostic EGD, CT scan of the abdomen is the imaging modality of choice to identify pancreatic pathology followed by angiography, gold
10
standard for detecting PAs.
10
10
9
• Coil embolization has a 79-100% success rate and a mortality rate of 12-33%. Coils, glue or non-coated metallic stents are acceptable depending
on the vessel tortuosity10 and infarct risk reduction.9
Table 2. Complications and Advantages to Coil Embolization
of Pseudoaneurysms
• If hemodynamically unstable or embolization has failed, surgery is recommended. Common
Complications
Advantages
9
procedures include bipolar arterial ligation, direct intra-pseudocystic ligation with drainage , Embolization of undesired vessel
Precise location
5
pancreaticoduodenectomy or splenopancreatectomy.
Assessment of collateral flow can be performed
Ischemia of organs lacking collateral circulation
Excellent alternative for poor surgical candidates
• The incidence of HP may rise in the future as a result of increasing alcohol use, primarily in Infection
Splenic infarct (Common since splenic artery
11
Less invasive compared to surgery
males in the western countries, leading to more cases of pancreatitis.
most commonly involved)
2

2

2-7

Conclusion
HP is a rare cause of an UGIB that is difficult to diagnose with endoscopy alone and often requires additional imaging. It should be included in the
differential for any male patient presenting with melena, generalized weakness and fatigue with a low hemoglobin with a history of pancreatitis that
can not be explained by a more common cause. Treatment by embolization should be attempted prior to surgical interventions. The incidence of HP
may rise with an increase in laparoscopic surgeries, the use of EUS-FNA and the continued trend of alcohol use inducing pancreatitis.
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